| Product Code: ETC7550323 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India Parkinson's disease market import shipment demonstrated remarkable growth with a high CAGR from 2020 to 2024. The market accelerated significantly from the previous year, indicating strong momentum and an expanding trend in the Parkinson's disease sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Parkinsons Disease Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 India Parkinsons Disease Market - Industry Life Cycle |
3.4 India Parkinsons Disease Market - Porter's Five Forces |
3.5 India Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 India Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 India Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 India Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in India |
4.2.2 Growing awareness about Parkinson's disease and its diagnosis |
4.2.3 Advancements in medical technology for Parkinson's treatment |
4.3 Market Restraints |
4.3.1 Lack of access to specialized healthcare facilities in rural areas |
4.3.2 High cost of Parkinson's disease medications and treatments |
4.3.3 Limited research and development in India specific to Parkinson's disease |
5 India Parkinsons Disease Market Trends |
6 India Parkinsons Disease Market, By Types |
6.1 India Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 India Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 India Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 India Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 India Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 India Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 India Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 India Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 India Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 India Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 India Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 India Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 India Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 India Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 India Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 India Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 India Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 India Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 India Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 India Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 India Parkinsons Disease Market Import-Export Trade Statistics |
7.1 India Parkinsons Disease Market Export to Major Countries |
7.2 India Parkinsons Disease Market Imports from Major Countries |
8 India Parkinsons Disease Market Key Performance Indicators |
8.1 Number of Parkinson's disease awareness campaigns conducted annually |
8.2 Percentage increase in the number of neurologists specializing in movement disorders |
8.3 Average wait time for Parkinson's disease diagnosis in major cities |
9 India Parkinsons Disease Market - Opportunity Assessment |
9.1 India Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 India Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 India Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 India Parkinsons Disease Market - Competitive Landscape |
10.1 India Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 India Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here